Skip to main content
Log in

The potentiation of the anti akinetic effect after L-Dopa treatment by an inhibitor of Mao-B, deprenil

  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Summary

The potentiation of the ami akinetic effect after L-Dopa treatment by an inhibitor of monoamine oxidase (MAO) “B”, Deprenil, has been demonstrated in parkinsonian patients with or without previous L-Dopa therapy. Application of the drug has been performed orally, intravenously and intramuscularly. Excellent kinetic effects resulted when combined with Madopar. The combined treatment with L-Dopa was highly effective when applicated i.v. or i.m.

Deprenil is an inhibitor of MAO-B and is characterized by less frequent side effects. These are predominantly involuntary movements and confusion, which can be eliminated by lowering the dosage of Deprenil.

A daily rhythm of MAO could be demonstrated in several areas of human brains as well in a control group as in parkinsonian patients with or without L-Dopa therapy. Maximal activity of MAO occurs between noon and 6 p.m.

The clinical and biochemical data are discussed regarding the off-phenomenons as Deprenil is an excellent drug for preventing these.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Anton, A. M., andD. F. Sayre: The distribution of Dopamine and Dopa in various animals and a method for their determination in diverse biological material. J. Pharmacol. Exp. Therap.145, 326 (1964).

    Google Scholar 

  • Barbeau, A.: Dopamine and basal ganglia disease. Arch. Neurol.4, 97–102 (1961).

    PubMed  Google Scholar 

  • Barbeau, A.: The clinical physiology of side effects in long-term L-Dopa therapy. In: Advances in Neurology, Vol. 5, pp. 347–365. New York: Raven Press. 1974.

    Google Scholar 

  • Bernheimer, H., W. Birkmayer, andO. Hornykiewicz: Verteilung des 5-Hydroxytryptamines (Serotonin) im Gehirn des Menschen und sein Verhalten bei Patienten mit Parkinson-Syndrom. Klin. Wschr.39, 1056 to 1059 (1961).

    Google Scholar 

  • Bernheimer, H., W. Birkmayer, andO. Hornykiewicz: Verhalten der Monoaminoxydase im Gehirn des Menschen nach Therapie mit Monoaminoxydase-Hemmern. Wr. klin. Wschr.74 (33/34), 558–559 (1962).

    Google Scholar 

  • Birkmayer, W., andO. Hornykiewicz: Der L-3, 4-Dioxyphenylalanin (L-Dopa) Effekt bei der Parkinson-Akinese. Wr. klin. Wschr.73, 787–788 (1961).

    Google Scholar 

  • Birkmayer, W., andO. Hornykiewicz: Der Dioxyphenylalanin (L-Dopa) Effekt beim Parkinson-Syndrom des Menschen. Arch. Psych.203, 560 to 571 (1962).

    Google Scholar 

  • Birkmayer, W., andE. Neumayer: Die moderne medikamentöse Behandlung des Parkinsonismus. Z. Neurol.202, 257–280 (1972).

    PubMed  Google Scholar 

  • Birkmayer, W., W. Danielczyk, E. Neumayer, andP. Riederer: L-Dopa Level in Plasma, Primary Condition for the Kinetic Effect. J. Neural Transm.34, 133–143 (1973).

    PubMed  Google Scholar 

  • Birkmayer, W., L. Ambrozi, E. Neumayer, andP. Riederer: Longevity in Parkinson's disease treated with L-Dopa. Clin. Neurol. and Neurosurg.1, 15–19 (1974).

    Google Scholar 

  • Calne, D. B., L. E. Claveria, andJ. G. Allen: Plasma Levodopa and the “On-Off” effect. In: Advances in Neurology, Vol. 5, pp. 341–356, New York: Raven Press. 1974.

    Google Scholar 

  • Carlsson, A., M. Lindqvist, T. Magnusson, andB. Waldeck: On the presence of 3-hydroxytyramine in brain. Science127, 471 (1958).

    PubMed  Google Scholar 

  • Coburn, S. P., M. Seidenberg, andR. W. Fuller: Daily rhythm in plasma tyrosine and phenylalanine. P.S.E.B.M.129, 338–343 (1968).

    Google Scholar 

  • Collins, G. G. S., M. Sandler, E. D. Williams, andM. B. H. Youdim: Multiple forms of human brain mitochondrial monoamine oxidase. Nature225, 817–820 (1970).

    PubMed  Google Scholar 

  • Collins, G. G. S., J. Pryse-Davies, M. Sandler, andJ. Southgate: Effect of pretreatment with Oestradiol, Progesterone and Dopa on monoamine oxidase activity in the rat. Nature226, 642–643 (1970 a).

    PubMed  Google Scholar 

  • Danielczyk, W.: Die Behandlung von akinetischen Krisen. Med. Welt24, 1278–1282 (1973).

    PubMed  Google Scholar 

  • Davison, A. N.: Physiological role of monoamine oxidase. Physiol. Rev.38, 729 (1958).

    PubMed  Google Scholar 

  • Duvoisin, R. C.: Variations in the “On-Off” phenomenon. In: Advances in Neurology, Vol. 5, pp. 339–340. New York: Raven Press. 1974.

    Google Scholar 

  • Ehringer, H., andO. Hornykiewicz: Verteilung von NA und Dopamin im Gehirn des Menschen und ihr Verhalten bei Erkrankungen des extrapyramidalen Systems. Klin. Wschr.38, 1236–1239 (1960).

    PubMed  Google Scholar 

  • Everett, G. M., andR. G. Wiegand: Central amines and behavioural states: a critique and new data. In: Proceedings of the 1st Internat. Pharmacol. Meeting, Vol. 8, Pharmacol. Analysis of central nervous action, pp. 85–92 (Paton, W. D. M., andP. Lindgren, eds.). Oxford: Pergamon Press. 1962.

    Google Scholar 

  • Fabn, S.: “On-Off” phenomenon with levodopa therapy in parkinsonism. Neurology 1974, 431–441.

  • Friedman, A. H., andCh. A. Walker: Circadian rhythms in rat mid-brain and caudate nucleus biogeinc amine levels. J. Physiol.197, 77–85 (1968).

    PubMed  Google Scholar 

  • Ganrot, P. O., E. Rosengren, andC. G. Gottfries: Effect of Iproniazid on monoamines and monoamine oxidase in human brain. Experientia1816, 260–261 (1962).

    Google Scholar 

  • Gey, K. F., A. Pleischer, andW. Burkard: Effect of inhibitors of monoamine oxidase on various enzymes and on the storage of monoamines. Annals of the New York Academy of Sciences107, 1147–1151 (1963).

    PubMed  Google Scholar 

  • Hanin, I., R. Massarelli, andE. Costa: Acetylcholine concentrations in rat brain: Diurnal oscillation. Science170 (3955), 341–342 (1970).

    PubMed  Google Scholar 

  • Holzbauer, M., andM. B. H. Youdim: Monoamine oxidase and Oestrouscycle. Brit. J. pharmacol.48, 600–608 (1973).

    Google Scholar 

  • Kraml, M.: A rapid microfluorimetric determination of monoamine oxidase. Biochem. Pharmacol.14, 1648–1685 (1965).

    Google Scholar 

  • Lloyd, K. G., L. Davidson, andO. Hornykiewicz: Metabolism of Levodopa in the human brain. In: Advances in Neurology, Vol. 3, pp. 173–188. New York: Raven Press. 1973.

    Google Scholar 

  • Lowry, O. H., N. J. Rosebrough, A. L. Farr, andR. J. Randall: Protein measurement with the Folin phenol reagent. J. Biol. Chem.193, 265–275 (1951).

    PubMed  Google Scholar 

  • Markham, C.H.: The “On-Off” side effect of L-Dopa. In: Advances in Neurology, Vol. 5, pp. 387–396. New York: Raven Press. 1974.

    Google Scholar 

  • Merck, E.: Klinisches Labor, 11. Aufl., pp. 128–134. Darmstadt: E. Merck. 1970.

    Google Scholar 

  • Okada, T., T. Fujita, T. Ohta, T. Kato, K. Ikuta, andT. Nagatsu: A 24-hour rhythm in human serum dopamine-β-hydroxylase activity. Experientia30/6, 605–607 (1974).

    Google Scholar 

  • Papavasiliou, S., G. C. Cotzias, andI. Mena: Short-and long-term approaches to the “On-Off” phenomenon. In: Advances in Neurology, Vol. 5, pp. 379–386. New York: Raven Press. 1974.

    Google Scholar 

  • Parvez, H., andS. Parvez: The rate limiting control of enzymes monoamine oxidase and catechol-O-methyl transferase in the foetus and the adult by adreno-cortical hormones. Experientia29, 1259–1262 (1973).

    PubMed  Google Scholar 

  • Piepho, R., andA. H. Friedman: Twenty-four hour rhythms in the glycine content of rat hindbrain and spinal cord. Life Sciences10, 1355–1362 (1971).

    Google Scholar 

  • Quay, W. B.: Differences in circadian rhythms in 5-hydroxy-tryptamine according to brain regions. Am. J. Physiol.215 (6), 1448–1453 (1968).

    PubMed  Google Scholar 

  • Riederer, P., W. Birkmayer, E. Neumayer, L. Ambrozi, andW. Linauer: The daily rhythm of HVA, VMA, (VA) and 5-HIAA in depressionsyndrom. J. of Neural Transm.35, 23–45 (1974).

    Google Scholar 

  • Robinson, D. S., J. M. Davis, A. Nies, C. L. Ravaris, andD. Sylvester: Relation of sex and aging to monoamine oxidase activity of human brain, plasma, and platelets. Arch. Gen. Psychiat.24, 536–539 (1971).

    PubMed  Google Scholar 

  • Sandier, M., andM. B. H. Youdim: Monoamine oxidase: the present status. Int. Pharmacopsychiat.9, 27–34 (1974).

    Google Scholar 

  • Scheving, I., W. H. Harrison, P. Gordon, andJ. E. Pauly: Daily fluctuations (circadian and ultradian) in biogenic amines of the rat brain. American J. Physiol.214 (1), 166–173 (1968).

    Google Scholar 

  • Sjoerdsma, A., W. Lovenberg, J. A. Oates, J. R. Crout, andS. Udenfriend: Alterations in the pattern of amine excretion in man produced by a monoamine oxidase inhibitor. Science130, 225 (1959).

    PubMed  Google Scholar 

  • Spector, S.: Effect of 6-OH-Dopa and L-Dopa on norepinephrine metabolism. In: Monoamines noyaux gris centraux et syndrome de Parkinsons (Symp. Bel-AIR IV, Genève Sept. 1970), pp. 159–163 (de Ajuriaguerra). Genève: G. Gauthier; Paris: Masson.

  • Spector, S., J. Tarver, andB. Berkowitz: Effects of drugs and physiological factors in the disposition of catecholamines in blood vessels. Pharmacol. Rev.24, 190–202 (1972).

    Google Scholar 

  • Sweet, R. D., andF. H. McDowell: The “On-Off” response to chronic L-Dopa treatment of parkinsonism. In: Advances in Neurology, Vol. 5, pp. 331–338. New York: Raven Press. 1974.

    Google Scholar 

  • Tagliamonte, A., R. Gessa, G. Biggio, L. Vargiu, andG. L. Gessa; Daily changes of free serum tryptophan in humans. Life Sciences14, 349–354 (1974).

    PubMed  Google Scholar 

  • Weil-Malherbe, H., H. S. Posner, andG. R. Bowles: Changes in the concentration and intracellular distribution of brain catecholamines: the effects of reserpine,β-phenylisopropylhydrazine, pyrogallol and 3, 4-dihydroxyphenylalanine, alone and in combination. J. Pharm. Exp, Ther.732, 278–286 (1961).

    Google Scholar 

  • Werder, K. V., G. R. Van Loon, F. Yatsu, andP. H. Forsham: Corticosteroid and growth hormones secretion in patients treated with L-dopa. Klin. Wschr.48, 1454 (1970).

    PubMed  Google Scholar 

  • Wurtman, R. J., Ch. Chou, andC. M. Rose: Daily rhythm in tyrosine concentration in human plasma: Persistence on low-protein diets. Science158, 660–662 (1967).

    PubMed  Google Scholar 

  • Yahr, M. D.: Variations in the “On-Off” Effect. In: Advances in Neurology, Vol. 5, pp. 397–404. New York: Raven Press. 1974.

    Google Scholar 

  • Youdim, M. B. H., andT. L. Sourkes: The effect of heat, inhibitors and riboflavin deficiency on monoamine oxidase. Can. J. Biochem.43, 1305 to 1318 (1965).

    Google Scholar 

  • Youdim, M. B. H., G. G. S. Collins, M. Sandier, A. B. Bevan Jones, C. M. B. Pare, andW. J. Nicholson: Human brain monoamine oxidase, multiple forms and selective inhibitors. Nature236, 225–228 (1972).

    PubMed  Google Scholar 

  • Youdim, M. B. H., M. Holzbauer, andH. F. Woods: Physico-chemical properties, development and regulation of central and peripheral monoamine oxidase activity. In: Neuropsychopharmacology of monoamines and their regulatory enzymes, pp. 11–28. New York: Raven Press. 1974.

    Google Scholar 

  • Youdim, M. B. H.: Monoamine oxidase: its inhibition. In: Recent Developments in Genetics and Psychopharmacology. Mod. Probl. Pharmacopsych., Vol. 10, pp. 65–88 (Mendlewicz, J., ed.). Basel: Karger. 1975.

    Google Scholar 

  • Zigmond, M. J., andR. J. Wurtman: Daily rhythm in the accumulation of brain catecholamines synthesized from circulating H3-tyrosine. J. Pharm. Exp. Ther.172 (2), 416–422 (1970).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Dedicated to Prof. Dr. J. Ariëns Kappers on the occasion of his 65th birthday.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Birkmayer, W., Riederer, P., Youdim, M.B.H. et al. The potentiation of the anti akinetic effect after L-Dopa treatment by an inhibitor of Mao-B, deprenil. J. Neural Transmission 36, 303–326 (1975). https://doi.org/10.1007/BF01253131

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01253131

Keywords

Navigation